Skip to main navigation Skip to search Skip to main content

LSD1-mediated epigenetic reprogramming drives CENPE expression and prostate cancer progression

  • Yi Liang
  • , Musaddeque Ahmed
  • , Haiyang Guo
  • , Fraser Soares
  • , Junjie T. Hua
  • , Shuai Gao
  • , Catherine Lu
  • , Christine Poon
  • , Wanting Han
  • , Jens Langstein
  • , Muhammad B. Ekram
  • , Brian Li
  • , Elai Davicioni
  • , Mandeep Takhar
  • , Nicholas Erho
  • , R. Jeffrey Karnes
  • , Dianne Chadwick
  • , Theodorus Van Der Kwast
  • , Paul C. Boutros
  • , Cheryl H. Arrowsmith
  • Felix Y. Feng, Anthony M. Joshua, Amina Zoubeidi, Changmeng Cai, Housheng H. He
  • Princess Margaret Cancer Center/University Health Network
  • University of Toronto
  • University of Massachusetts Boston
  • German Cancer Research Center
  • Dana-Farber Cancer Institute
  • Brigham and Women’s Hospital
  • Harvard University
  • GenomeDX Biosciences Inc.
  • Mayo Clinic Rochester, MN
  • University Health Network
  • Toronto General Hospital
  • Ontario Institute for Cancer Research
  • University of California at San Francisco
  • St Vincent's Hospital
  • VANCOUVER

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)5479-5490
Number of pages12
JournalCancer Research
Volume77
Issue number20
DOIs
StatePublished - Oct 15 2017

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'LSD1-mediated epigenetic reprogramming drives CENPE expression and prostate cancer progression'. Together they form a unique fingerprint.

Cite this